Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1976 1
1981 5
1982 1
1983 1
1984 1
1985 4
1986 1
1987 2
1988 1
1989 5
1990 7
1991 6
1992 8
1993 6
1994 8
1995 11
1996 9
1997 7
1998 14
1999 18
2000 11
2001 13
2002 17
2003 21
2004 24
2005 28
2006 20
2007 26
2008 29
2009 38
2010 27
2011 28
2012 35
2013 39
2014 24
2015 36
2016 41
2017 34
2018 40
2019 38
2020 43
2021 44
2022 40
2023 31
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

773 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Severely reduced visual acuity"
Page 1
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
Liao DS, Grossi FV, El Mehdi D, Gerber MR, Brown DM, Heier JS, Wykoff CC, Singerman LJ, Abraham P, Grassmann F, Nuernberg P, Weber BHF, Deschatelets P, Kim RY, Chung CY, Ribeiro RM, Hamdani M, Rosenfeld PJ, Boyer DS, Slakter JS, Francois CG. Liao DS, et al. Ophthalmology. 2020 Feb;127(2):186-195. doi: 10.1016/j.ophtha.2019.07.011. Epub 2019 Jul 16. Ophthalmology. 2020. PMID: 31474439 Free article. Clinical Trial.
PURPOSE: Geographic atrophy (GA), a late stage of age-related macular degeneration (AMD), is a major cause of blindness. Even while central visual acuity remains relatively well preserved, GA often causes considerable compromise of visual function and quality …
PURPOSE: Geographic atrophy (GA), a late stage of age-related macular degeneration (AMD), is a major cause of blindness. Even while central …
Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group.
[No authors listed] [No authors listed] Arch Ophthalmol. 1995 Dec;113(12):1479-96. Arch Ophthalmol. 1995. PMID: 7487614 Clinical Trial.
RESULTS: There was no difference in final visual acuity or media clarity with or without the use of systemic antibiotics. In patients whose initial visual acuity was hand motions or better, there was no difference in visual outcome whether or no …
RESULTS: There was no difference in final visual acuity or media clarity with or without the use of systemic antibiotics. In p …
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.
Brown DM, Wykoff CC, Boyer D, Heier JS, Clark WL, Emanuelli A, Higgins PM, Singer M, Weinreich DM, Yancopoulos GD, Berliner AJ, Chu K, Reed K, Cheng Y, Vitti R. Brown DM, et al. JAMA Ophthalmol. 2021 Sep 1;139(9):946-955. doi: 10.1001/jamaophthalmol.2021.2809. JAMA Ophthalmol. 2021. PMID: 34351414 Free PMC article. Clinical Trial.
OBJECTIVE: To evaluate vascular endothelial growth factor blockade therapy with intravitreal aflibercept injections in eyes with severe NPDR without diabetic macular edema (DME). DESIGN, SETTING, AND PARTICIPANTS: The Study of the Efficacy and Safety of Intravitreal Aflibe …
OBJECTIVE: To evaluate vascular endothelial growth factor blockade therapy with intravitreal aflibercept injections in eyes with severe …
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Writing Committee for the Diabetic Retinopathy Clinical Research Network; Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, Baker CW, Berger BB, Bressler NM, Browning D, Elman MJ, Ferris FL 3rd, Friedman SM, Marcus DM, Melia M, Stockdale CR, Sun JK, Beck RW. Writing Committee for the Diabetic Retinopathy Clinical Research Network, et al. JAMA. 2015 Nov 24;314(20):2137-2146. doi: 10.1001/jama.2015.15217. JAMA. 2015. PMID: 26565927 Free PMC article. Clinical Trial.
IMPORTANCE: Panretinal photocoagulation (PRP) is the standard treatment for reducing severe visual loss from proliferative diabetic retinopathy. ...Secondary outcomes included visual acuity area under the curve, peripheral visual field lo …
IMPORTANCE: Panretinal photocoagulation (PRP) is the standard treatment for reducing severe visual loss from proliferat …
Preventing Myopia.
Lagrèze WA, Schaeffel F. Lagrèze WA, et al. Dtsch Arztebl Int. 2017 Sep 4;114(35-36):575-580. doi: 10.3238/arztebl.2017.0575. Dtsch Arztebl Int. 2017. PMID: 28927495 Free PMC article.
This would lessen the prevalence and severity of myopia and also lower the risk of secondary diseases that impair visual acuity. ...Two meta-analyses and a large randomized clinical trial from Asia have shown that the progression of myopi …
This would lessen the prevalence and severity of myopia and also lower the risk of secondary diseases that impair visual ac …
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
OBJECTIVE: To compare the primary 4-year outcomes of visual acuity and rates of vision-threatening complications in eyes with moderate to severe NPDR treated with intravitreal aflibercept compared with sham. The primary 2-year analysis of this study has been …
OBJECTIVE: To compare the primary 4-year outcomes of visual acuity and rates of vision-threatening complications in eyes with …
Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7.
[No authors listed] [No authors listed] Ophthalmology. 1991 May;98(5 Suppl):741-56. doi: 10.1016/s0161-6420(13)38009-9. Ophthalmology. 1991. PMID: 2062510 Clinical Trial.
The Early Treatment Diabetic Retinopathy Study (ETDRS), a multicenter collaborative clinical trial supported by the National Eye Institute, was designed to assess whether argon laser photocoagulation or aspirin treatment can reduce the risk of visual l …
The Early Treatment Diabetic Retinopathy Study (ETDRS), a multicenter collaborative clinical trial supported by the National E …
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.
[No authors listed] [No authors listed] Arch Ophthalmol. 1985 Dec;103(12):1796-806. Arch Ophthalmol. 1985. PMID: 2866759 Clinical Trial.
In this randomized clinical trial, which was supported by the National Eye Institute, 754 eyes that had macular edema and mild to moderate diabetic retinopathy were randomly assigned to focal argon laser photocoagulation, while 1,490 such eyes were …
In this randomized clinical trial, which was supported by the National Eye Institute, 754 eyes that had macular edema a …
Current Management of Childhood Amblyopia.
Park SH. Park SH. Korean J Ophthalmol. 2019 Dec;33(6):557-568. doi: 10.3341/kjo.2019.0061. Korean J Ophthalmol. 2019. PMID: 31833253 Free PMC article. Review.
Amblyopia is defined as the reduction of best-corrected visual acuity of one or both eyes caused by conditions that affect normal visual development. ...Given the success of amblyopia treatment declines with increasing age, the detection and management of amb …
Amblyopia is defined as the reduction of best-corrected visual acuity of one or both eyes caused by conditions that affect nor …
Amniotic membrane transplantation for acute ocular burns.
Clare G, Bunce C, Tuft S. Clare G, et al. Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD009379. doi: 10.1002/14651858.CD009379.pub3. Cochrane Database Syst Rev. 2022. PMID: 36047788 Free PMC article. Review.
The outcome measures were failure of re-epithelialisation by day 21 post injury, visual acuity at final follow-up, corneal neovascularisation, symblepharon, time to re-epithelialisation and adverse effects. ...The GRADE assessment for adverse effects was therefore c …
The outcome measures were failure of re-epithelialisation by day 21 post injury, visual acuity at final follow-up, corneal neo …
773 results